Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen'an decoction
- Development stage
- Phase 1
- Lead developer
- Hospital Affiliated to Changchun University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Shen'an decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Affiliated Hospital of Changchun University of Chinese Medicine. It is primarily investigated for the treatment of diabetic nephropathy (DN) in patients with type 2 diabetes mellitus. The decoction is intended to improve renal function and reduce proteinuria, potentially by modulating inflammatory and fibrotic pathways associated with chronic kidney damage in diabetic patients. It has been evaluated in randomized controlled clinical trials in China, where its efficacy and safety are compared against standard-of-care treatments such as the angiotensin II receptor blocker valsartan.
- Other names
- Shenan decoction
Beyond the preview
Go deeper on Shen'an decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shen'an decoction.